Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-26-000045·Altimmune, Inc.
Schedule 13G ownership disclosure
Altimmune Inc
Common Stock · CUSIP: 02155H200
Event date: 2025-12-31
- Filing-level shares
- 9,491,159
- Percent of class
- 9.09%
- The Vanguard Group
Shares: 9,491,159 · Class: 9.09%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-26-000045
- Form type
- SCHEDULE 13G/A
- Filer
- Altimmune, Inc.
- CIK
- CIK 1326190
- Filed
- Jan 30, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership